Publications by authors named "T Stompor"
Background: This study aimed to characterize acute coronary syndrome (ACS) patients undergoing invasive diagnostics and to evaluate prognostic factors for all-cause mortality over a 10-year follow-up period.
Methods: The KORONEF study was a prospective, observational, single-center study that enrolled 492 patients, of whom 467 had confirmed coronary artery disease (CAD). Baseline demographic, clinical, laboratory, and procedural data were analyzed, focusing on the differences between ACS and chronic coronary syndrome (CCS) patients.
Article Synopsis
- Skeletal muscle relaxants are commonly used in anesthesia for surgeries, mechanical ventilation, and intubation, creating a conduction block at the neuromuscular junction.
- Reversal agents, like neostigmine and sugammadex, help terminate the neuromuscular blockade and prevent residual effects, but their efficacy can be affected by liver and kidney dysfunction.
- Liver damage, which can stem from various causes including drug toxicity and metabolic disorders, impairs drug metabolism and can lead to systemic complications, ultimately impacting the use of muscle relaxants in patients with liver disease.
Both chronic kidney disease (CKD) and type 2 diabetes (T2D) are modern epidemics worldwide and have become a severe public health problem. Chronic kidney disease progression in T2D patients is linked to the need for dialysis or kidney transplantation and represents the risk factor predisposing to serious cardiovascular complications. In recent years, important progress has occurred in nephroprotective pharmacotherapy in CKD patients with T2D.
View Article and Find Full Text PDFArticle Synopsis
- Patients with nephrotic syndrome (NS) are at higher risk for acute ischemic stroke (aIS) and intracranial hemorrhage (ICH), but the specific risk factors for these outcomes were previously unclear.
- A study analyzed a cohort of NS patients from 2010-2021, identifying significant stroke risk factors including diabetes mellitus, diabetic nephropathy, smoking, prior arterial thromboembolic events, and being over 55 years old.
- Contrary to expectations, the use of low molecular weight heparin did not lower stroke risk, and the findings emphasize the need for careful management of high-risk NS patients.